Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-08 · accession 0001439222-24-000144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-13 | 2024-11-08 | AGIO | Washburn Theodore James Jr. | Principal Accounting Off | S - Sale | $56.09 | -772 | 813 | -49% | -$43.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-11-08 | S | D | 772 | $56.09 | 813 | D | — | — | (F1) Consists of 813 shares purchased through the Company's employee stock purchase plan. |